Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer.
The effect of blocking VEGF activity in solid tumors extends beyond inhibition of angiogenesis. However, no studies have compared the effectiveness of mechanistically different anti-VEGF inhibitors with respect to changes in tumor growth and alterations in the tumor microenvironment. In this study w...
Guardado en:
Autores principales: | Christina L Roland, Kristi D Lynn, Jason E Toombs, Sean P Dineen, D Gomika Udugamasooriya, Rolf A Brekken |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1f8ba5d37820475c9124a92a94922d4e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CYTOKINES AS MARKERS OF THE INFILTRATIVE PULMONARY TUBERCULOSIS DEVELOPMENT
por: M. V. Mezentseva, et al.
Publicado: (2014) -
VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV.
por: Hu Huang, et al.
Publicado: (2013) -
Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models
por: Nan Li, et al.
Publicado: (2021) -
Maximizing the potential of aggressive mouse tumor models in preclinical drug testing
por: M. Tarek Elghetany, et al.
Publicado: (2021) -
HIF-VEGF pathways are critical for chronic otitis media in Junbo and Jeff mouse mutants.
por: Michael T Cheeseman, et al.
Publicado: (2011)